Incannex Healthcare stock tumbles after filing $100M offering
SAN JOSE, Calif. & TEMPE, Ariz. - Align Technology, Inc. (NASDAQ:ALGN), recognized for its Invisalign® clear aligners, has announced the commercial release of a new product designed to correct Class II malocclusions in younger patients. The Invisalign System with mandibular advancement now includes occlusal blocks, a feature aimed at addressing both skeletal and dental corrections by advancing the lower jaw while straightening teeth.
This addition to Align’s portfolio is targeted at treating patients aged 10-16, during the late mixed or early permanent dentition stages. The integration of occlusal blocks is intended to provide a more durable and effective solution, potentially reducing the need for multiple appliances and streamlining the treatment process. The blocks are constructed with solid laser welding to resist crushing and allow for vertical opening, which can initiate the mandibular advancement phase sooner in certain cases.
The company emphasizes that this innovation leverages the natural growth phase of pre-adolescents and adolescents to correct Class II malocclusions, which represent a significant portion of orthodontic issues worldwide. By improving occlusal relationships and facial aesthetics, the treatment also aims to deliver long-term functional benefits. With an impressive 70% gross profit margin and a "GOOD" overall financial health score according to InvestingPro, Align Technology demonstrates strong operational efficiency in its innovative product development.
Align Technology’s EVP, Sreelakshmi Kolli, stated that this latest development underscores their commitment to expanding the Invisalign System’s capabilities, allowing for a broader range of malocclusions to be treated with precision and efficiency. Clinical feedback suggests that the new system is comparable to traditional functional appliances in terms of treatment outcomes, with added benefits of enhanced comfort and compliance due to the SmartTrack™ material used in the aligners.
The Invisalign System with mandibular advancement featuring occlusal blocks is now available to Invisalign-trained doctors in Australia and New Zealand, with a limited release in North America and most EMEA countries. A wider introduction is expected throughout 2025. This product joins a suite of offerings from Align Technology designed to support the continuum of care for growing patients. Analysts maintain a positive outlook on the company’s growth potential, with consensus price targets suggesting significant upside potential. For detailed analysis and additional insights, investors can access the comprehensive Pro Research Report available on InvestingPro, which covers this and 1,400+ other top US stocks.
This article is based on a press release statement from Align Technology, Inc.
In other recent news, Align Technology has been the focus of several analyst updates and financial assessments. Mizuho Securities adjusted its price target for Align Technology to $250, down from $295, while maintaining an Outperform rating. This revision reflects a more cautious approach due to tariffs in Mexico and adjusted earnings per share forecasts for 2025 to 2027. Meanwhile, Stifel maintained a Buy rating with a $275 price target, citing a stabilization in market share for Align’s Invisalign product, particularly in China. They noted that despite recent poor consumer sentiment, Invisalign’s Google Trends data remains strong.
Piper Sandler also revised their outlook, cutting the price target to $235 from $270, maintaining a Neutral rating. They highlighted a 12% year-over-year decline in aligner volumes in February, attributing part of the downturn to weather-related disruptions. Despite these challenges, Piper Sandler emphasized the strength of Align’s other business areas, such as iTero and international volumes. Stifel analysts further identified Align Technology as a potential investment opportunity, recommending a portfolio allocation for investors with a higher risk tolerance, due to its robust Google trends and current trading multiples. These developments indicate varying perspectives from analysts on Align Technology’s performance and future potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.